YM443 in Subjects With Functional Dyspepsia

Clinical trial NCT00102310 · COMPLETED

Trial details

NCT number: NCT00102310
Sponsor: Astellas Pharma Inc
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Indigestion Nausea

Start date: 2004-03-10
Primary completion: 2006-03-11
Enrollment: 416

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.